dyclonine has been researched along with Disease Exacerbation in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dyclonine which was found to have antioxidant activity and would benefit patients with Friedreich's ataxia, is a commonly used local anesthetic." | 1.91 | Dyclonine relieves the Parkinson's disease progression in rotenone-induced Drosophila model. ( Guo, J; Li, M; Li, Y; Ling, L; Liu, F; Luo, S; Ma, B; Wang, H, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M | 1 |
| Luo, S | 1 |
| Li, Y | 2 |
| Ma, B | 1 |
| Liu, F | 1 |
| Wang, H | 1 |
| Guo, J | 1 |
| Ling, L | 1 |
1 other study available for dyclonine and Disease Exacerbation
| Article | Year |
|---|---|
Dyclonine relieves the Parkinson's disease progression in rotenone-induced Drosophila model.
Topics: Animals; Disease Progression; Dopaminergic Neurons; Drosophila; Neuroprotective Agents; NF-E2-Relate | 2023 |